Lumi Research

Houston, Texas 77090

5 studies enrolling now · 7 studies all time

What they study most

Advanced/Metastatic Non-Small Cell Lung Cancer, Anemia, Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung, HER2-low Hormone Receptor Positive Breast Cancer, Melanoma (Skin Cancer), Multiple Myeloma, Myelodysplastic Syndrome, Myelofibrosis, Neoplasm Metastasis, Non-Small Cell Lung Cancer

Studies at this site

• A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib — Recruiting now
• Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers — Recruiting now
• A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions — Recruiting now
• A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer — Recruiting now
• Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors — Recruiting now
• A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer — Running, not enrolling
• A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma — Stopped early